541304 — Indo US Bio-Tech Balance Sheet
0.000.00%
- IN₹3.26bn
- IN₹3.40bn
- IN₹728.36m
- 89
- 12
- 16
- 31
Annual balance sheet for Indo US Bio-Tech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 2 | 1.32 | 0.492 | 1.9 | 11 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 225 | 261 | 234 | 328 | 202 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 319 | 381 | 468 | 599 | 731 |
Net Property, Plant And Equipment | 26.8 | 43.2 | 78.8 | 87.3 | 105 |
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 347 | 437 | 556 | 695 | 845 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 170 | 180 | 123 | 123 | 175 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 183 | 221 | 171 | 150 | 217 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 164 | 215 | 385 | 545 | 627 |
Total Liabilities & Shareholders' Equity | 347 | 437 | 556 | 695 | 845 |
Total Common Shares Outstanding |